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Human Eosinophils Synthesize and Secrete Interleukin-6, In Vitro
By Qutayba Hamid, Julia Barkans, Qiu Meng, Sun Ying, John S. Abrams, A. Barry Kay, and Redwan Moqbel Using the technique of in situ hybridization, we have shown that resting, unstimulated, human peripheral blood eosinophils, obtained from subjects with greater than 8% eosinophilia, transcribe and translate messenger RNA (mRNA) for interleukin-6 (IL-6). After incubation for 24 hours in culture medium alone, approximately 19% of eosinophils were positive for IL-6 mRNA. This may be a reflection of their in vivo activation, but also may suggest that the gene for this cytokine is constitutively expressed in eosinophils. After stimulation with interferon y (IFNy) (500 U/mL), the percentage of IL-&mRNA+ cells increased to 51.3%. This was accompanied by an enhancement of intensity of the hybridization signals. The specificity of the IL-6 probe and the hybrid-NTERLEUKIN-6 (IL-6) is a 26-Kd protein released by a I wide range of immune, inflammatory, and tissue This cytokine is an important element of the immune reaction through its ability to stimulate both humoral and cellular defence mechanisms. The diversity of biologic activities of IL-6 include: B-cell terminal differentiation, stimulation of plasmacytoma and hybridoma growth, induction of acute-phase protein synthesis, stimulation of hematopoietic progenitors, and activation of T cells and thymocytes.l.z IL-6 has been shown to be released by the Th2 subset of T c e k 3 Th2-type cytokines, ie, IL-4 and IL-5, as well as IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF), are believed to be important in the regulation of atopic allergic inflammation in humans, and cytokine messenger RNA+ (mRNA+) cells were identified in cutaneous allergen-induced late-phase reactions and bronchial biopsies from atopic a~t h m a .~?~ The production of these cytokines by activated T lymphocytes6 and mast cell^^,^ is well documented. However, the full potential of eosinophils, prominent cells in the inflammatory infiltrate in allergic and helminthic diseases, as cytokine-producing cells is not yet fully elucidated.
We have recently shown that activated human eosinophils express mRNA for GM-CSF and that this protein was synthesized in the cell.9 This observation was further confirmed by Kita et milliliter amounts of GM-CSF and IL-3 in supernatants of stimulated, but not resting, eosinophils and showed a role for eosinophil-derived GM-CSF and IL-3 in prolonging the survival of these cells in vitro. In addition, Wong et all1 have shown the release of transforming growth factor-a (TGF-a) from human eosinophils and have recently proposed an in vivo role for the eosinophil TGF-a in healing cutaneous wounds in rabbits.'* Del Pozo et all3 have reported that murine eosinophils express mRNA for IL-la.
The aims of this study were to examine the expression of IL-6 gene transcript (mRNA) in resting and stimulated eosinophils and to investigate whether immunoreactive IL-6 is stored and secreted. The release of IL-6 by eosinophils may have important implications on our current understanding of the role of eosinophils in inflammatory reactions associated with allergy.
MATERIALS AND METHODS

Eosinophils.
Eosinophils were obtained from the peripheral blood of subjects with eosinophilia of greater than 8% in association with atopy or helminthic infection. The mean percentage of eosinophil purity (as determined by Kimura staid4 and confirmed by differential counts using May-Griinwald-Giemsa) using discontinuous metrizamide gradient@ was 95.4% 2 1.1% (range, 90.0% to 99.8%). Neutrophils were the major contaminating cells.
Eosinophils were incubated under sterile conditions with either culture medium alone or recombinant IFNy (r-IFNy) (500 U/mL) (kind gift from Dr Paul Winter, Biogen Research Corp, Cambridge, MA). r-IFNy has been shown to upregulate eosinophil-effector function9J6 and receptor expression." Stimulation was for 24 hours in culture medium, which consisted of RPMI-1640 supplemented with 10% fetal calf serum (FCS), 50 kmol/L 2-mercaptoethanol, 2 mmol1L L-glutamine, 100 U/mL penicillin, 100 kg/mL streptomycin, and 50 &mL gentamycin. Ribonucleoside vanadyl complex (20 mmol/L; Sigma Chemicals Ltd, Poole, UK) was added to the cell suspension before preparing cytospins to inactivate eosinophil ribonuclease (RNase). Cytospins were prepared on poly-L-lysinexoated slides, fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS), and washed twice in 15% sucrose in PBS.
In situ hybridization was performed as previously Briefly, cDNA for IL-6 (1,100 bp) was inserted into a pGEM-4 vector, linearized with Sma I and BamHI for antisense and sense templates, respectively. These riboprobes were transcribed in the presence of 35S-UTP and T7 and SP6 RNA
Cell stimulation.
In situ hybridization. iodoacetamide, and N-ethylmaleimide. Antisense or sense probes (1 to 1.5 x lo6 cpm/slide) in hybridization buffer containing dithiothreitol(lO0 mmol/L) were heated to 60°C for 1 hour before hybridization (16 hours at 40°C). During high stringency (4x SSC to 0.1 x SSC at 45°C to 50°C) posthybridization washings, unhybridized single stranded RNA was removed by RNase-A. Autoradiography was followed by counterstaining with either hematoxylin or carbo1 chromotrope 2R. Transformed bronchial epithelial cells (9HTEo-),l9 shown to synthesize and release IL-6,20 were used as controls for IL-6 mRNA hybridization. Negative controls included the IL-6 sense probe and cytospins treated with RNase-A solution before hybridizing with the antisense probe. The percentage of positive cells was determined by "blind" counting greater than 1,000 cells per cytospin, using an eyepiece graticule, as described! Total RNA was extracted from 10 x lo9 purified (95%) eosinophils, obtained from a patient with the hypereosinophilic syndrome in the absence of any stimulation, by guanidine isothiocynate and purified by centrifugation on cesium chloride gradients.21 A sample of 10 pg RNA was size-fractionated on a 1% agarose/2% formaldehyde gel and transferred onto a nylon filter. Northern blotting was performed as previously described." Briefly, the filter was prehybridized for 6 hours at 68°C and hybridized for 16 hours at 68°C with an IL-6 cDNA probe labeled with [32P]dCTP by random priming and diluted in hybridization buffer. The filter was washed at 68°C with a solution of 0.1 x SSC, 0.5% sodium dodecyl sulfate (SDS), and exposed to X-AR film at -70°C.
Immunocytochemistry. Immunocytochemistry was performed using the alkaline phosphatase anti-alkaline phosphatase (APAAP) method as previously de~cribed.2~ A goat IgG antihuman IL-6 antibody (a-IL-6; British Bio-technology, Abingdon, UK) was selected for its ability to neutralize the bioactivity of both recombinant and natural human IL-6 with no crossreactivity with IL-la or P, IL-2, IL-3, IL-4, tumor necrosis factor a (TNFa), TNFP, GM-CSF, or G-CSF. Cytospins were washed in Tris-buffered saline (TBS). a-IL-6 was added at a final concentration of 100 pg/mL and allowed to incubate overnight (4°C). Slides were briefly washed in TBS. APAAP-conjugated rabbit antigoat was added at 1:40 dilution and developed with Fast Red (TR Salt; Sigma Chemical Co, Poole, UK). Transfected bronchial epithelial cells were again used as a positive control.
To ascertain the sublocalization of IL-6 mRNA to eosinophils, we have simultaneously applied radiolabeled IL-6 cRNA and eosinophil-specific monoclonal antibody (MoAb). This was performed according to the method of Chan-Palay et Briefly, cytospin preparations of IFNy-stimulated human eosinophils were hybridized with IL-6 antisense riboprobe, as described above. To preserve the immunoreactivity of eosinophil granule antigens, dextran sulphate was omitted from the hybridization buffer. Immunocytochemistry (APAAP technique) was performed immediately after the final SSC wash using a mouse MoAb (EG2) that binds to the cleaved (secreted) form of eosinophil cationic pr0tein,2~1~ thus recognizing activated eosinophils.
An immunoenzymetric assay was used to determine the amounts of IL-6 in the supernatants of eosinophil cultures using a basic cytokine immunoenzymetric assay format described previously for IL-3, IL-5, and GM-CSF.'O Briefly, a mouse monoclonal capture antibody, 4-IL-6, was used, to which was added the supernatants, followed by a ni- 
RESULTS
Hybridization between radiolabeled cRNA probes and mRNA encoding IL-6 in cytospin preparations was shown by specific deposits of silver grains in individual cells (Fig  1) . A mean of 19% of eosinophils treated with medium alone (unstimulated) were IL-6 mRNA+. The degree of in vivo activation of these cells was determined by staining with EG2 MoAb to detect secretory eosinophil cationic protein (ECP). An average of 8% of these cells were EG2+. The percentage of IL-6 mRNA+ cells increased to 51.3% after 24 hours of incubation with IFNy (Table l) , whereas the average EG2+ cell count was 92%. The specificity of the IL-6 mRNA+ signals was confirmed by the presence of intense hybridization signals in the 9 H m o -cells (positive control, as they elaborate IL-6), and the absence of hybridization signals in parallel cytospin preparations treated with IL-6 sense probe or digested with RNAse before hybridization with IL-6 antisense probe. Further confirmation was obtained by Northern blot analysis (Fig 2) of total RNA extracted from eosinophils obtained from a patient with the hypereosinophilic syndrome and incubated for 24 hours in medium alone. Hybridization for IL-6 mRNA was shown by a band (1.3 kb) that was identical with that obtained for IL-&positive control (transformed bronchial epithelial cell line, HTEO-).~O Using a polyclonal goat antihuman IL-6 antibody, IL-6 immunoreactivity was localized in cytospins of both resting and stimulated eosinophils (Table 2) . No specific staining was observed with cells stained with normal goat IgG.
It was possible to ensure the identity of the mRNA+ cells by showing discrete silver grains on chromotrope 2R-stained eosinophils. Furthermore, we were able to colocalize IL-6 mRNA and EG2, thus confirming the association between IL-6 mRNA and eosinophils.
Using a specific immunoenzymetric technique, picogram per milliliter amounts of IL-6 from cultured eosinophil supernatants (from both resting and IFNy-treated cells) were measured (Table 3) .
In each case, an IFNy-induced increase in supernatant IL-6 was observed, compared with medium alone, for in vitro cultured eosinophils (24 or 48 hours) obtained from different donors.
DISCUSSION
Our results indicated that human eosinophils have the capacity to generate IL-6, in addition to GM-CSF,9J0 IL-3,lo and TGF-a.I1 These findings extend the number of proinflammatory cytokines synthesized by, and released use only. from, human eosinophils, in vitro, and provide further insight into the complex nature of the biology of this inflammatory cell. Therefore, in addition to basic proteins and lipid mediator release,26 eosinophil-derived cytokines, including IL-6, may contribute to eosinophil involvement in allergic inflammation. Further studies are needed to address whether eosinophil IL-6 induction kinetics are as rapid as that of monocytes or cells of other lineages.
Eosinophils, both resting and stimulated, gave clear hybridization signals with the IL-6 antisense, but not sense, riboprobe. The localization of mRNA expression in approximately one-fifth of unstimulated eosinophil population, and the presence of EG2+ cells, suggests that a percentage of circulating eosinophils, obtained from eosinophilic ( > 8%) donors, were activated. This does not exclude the possibility that the gene encoding for this cytokine may be constitutively expressed in some of these cells. The percentage of IL-6 mRNA+ cells was increased after stimulation, suggesting that IL-6 expression is inducible with IF'Ny.
IFNy was used to stimulate eosinophils at a dose equivalent to 750 pmol/L. This concentration of IFNy was higher than the levels measured in plasma of patients with asth- ma?' However, it is likely that local levels of this cytokine at sites of inflammatory reaction is much greater. The gene for IL-6 encodes an mRNA of 1.3 khZ8 This was consistent with the size of the band we obtained by Northern blot analysis of total mRNA from unstimulated eosinophils obtained from a hypereosinophilic syndrome patient (Fig 2) . The latter confirmed the specificity of the probe we used for the in situ hybridization. Further evidence for the specificity of the IL-6 mRNA signal was the absence of specific signals in preparations treated with the sense probe or those pretreated with RNase. The nonspecific attachment of the 3sS label to eosinophils was prevented by the use of a number of autoradiographic reducing agents and a high concentration of dithiothreitol throughout the hybridization procedure.
We have carefully examined the cell localization of IL-6 mRNA hybridization signals and ascertained that they were eosinophil-associated and not attributable to other leukocyte types present as contaminating cells (Fig 1A) . A combination of in situ hybridization with eosinophil-specific staining (carbo1 chromotrope 2R) and immunocytochemistry using eosinophil-specific antibody (EG2) confirmed the colocalization of IL-6 mRNA to eosinophils (Fig 1) . It is also worth noting that the mean purity of the eosinophils used in this study was greater than 95%, whereas the mean percentage of IL-6 mRNA+ cells was between 4-and 10-fold higher than the maximum percentages of contaminating cells.
Evidence for translation of IL-6 mRNA in eosinophils was obtained by immunocytochemical staining with an a-human IL-6 antibody in both resting and stimulated eosinophils. In addition, the identification of picogram amounts of IL-6 in supernatants of normal and IFNytreated human eosinophils provides important additional evidence to support the fact that this cell type has the capacity to synthesize, store, and secrete IL-6. Although we recognize that the present report does not indicate whether eosinophils in fact produce IL-6 in vivo, it does indicate that they have the capacity to make this cytokine under certain in vitro conditions. Whether this has a function in vivo, or simply reflects a certain "myeloidlineage behavior" of this cell type remains to be elucidated. IL-6 has been shown to act as an important helper factor in primary antigen-dependent T-cell activation and their subsequent p r~l i f e r a t i o n .~~ T cells, especially CD4+, have been shown to be important components of the inflammatory infiltrate in antigen-induced late-phase allergic reactions in human skin,22 lung,?" and nose.31 IL-6 has also been reported to participate in IL-4-dependent IgE synthesis.32 Furthermore, IL-6 acts in synergism with IL-3 and GM-CSF to enhance the proliferation and growth of multipotential hematopoietic (granulocytic) progenitors in human^.^^,^^ IL-6 is also involved in promoting secretion of IgA in mucosal tissue during inflammatory r e a~t i o n s .~J J~ Secretory IgA has been shown to be a very potent trigger of eosinophil degran~lation.?~ IL-6 has also been shown to have a growth-inhibitory role against fibroblast^.^^ The "repair" function of the latter cells may, therefore, be influenced by the IL-6 derived from eosinophil-rich inflammatory reaction, and it is possible that eosinophil-derived IL-6 may play a role in allergic inflammation. A homeostatic role for eosinophil-derived IL-6 also cannot be excluded. IL-6 is released in association with protective responses against infectious and parasitic agents1** and this may be relevant to the elevation in eosinophil numbers in helminth-induced inflammati~n.~' In addition, the gene for IL-6 has been shown to be transcribed at high levels in organs (spleen, liver, and kidney) and peripheral blood leukocytes of normal individua1s.Q
In conclusion, we have shown that human eosinophils are capable of synthesizing and elaborating the multifunctional cytokine IL-6. Whether eosinophil-derived IL-6 has a role in eosinophil effector function remains to be shown by in situ studies on affected tissue.
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